AAV2/8-TYMP gene therapy(Universitat Autonoma de Barcelona/Columbia University)

N/A

Report date: 2025/01/26 18:05:18

Base Information

Drug NameAAV2/8-TYMP gene therapy(Universitat Autonoma de Barcelona/Columbia University)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionThymidine phosphorylase stimulants
TargetsThymidine phosphorylase
Therapy Area/IndicationsMitochondrial Encephalomyopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversitat Autonoma De Barcelona
China Registration ClassN/A

Develop Information

Active CompaniesUniversitat Autonoma De BarcelonaColumbia University Medical Center
Inactive CompaniesN/A
Active IndicationsMitochondrial Encephalomyopathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A